Richard A. Edlin - Net Worth and Insider Trading
Richard A. Edlin Net Worth
The estimated net worth of Richard A. Edlin is at least $94,016 dollars as of 2024-04-28. Richard A. Edlin is the Director of Eagle Pharmaceuticals Inc and owns about 22,600 shares of Eagle Pharmaceuticals Inc (EGRX) stock worth over $94,016. Details can be seen in Richard A. Edlin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard A. Edlin has not made any transactions after 2022-09-06 and currently still holds the listed stock(s).
Transaction Summary of Richard A. Edlin
Richard A. Edlin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard A. Edlin owns 1 companies in total, including Eagle Pharmaceuticals Inc (EGRX) .
Click here to see the complete history of Richard A. Edlin’s form 4 insider trades.
Insider Ownership Summary of Richard A. Edlin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EGRX | Eagle Pharmaceuticals Inc | 2022-09-06 | director |
Richard A. Edlin Latest Holdings Summary
Richard A. Edlin currently owns a total of 1 stock. Richard A. Edlin owns 22,600 shares of Eagle Pharmaceuticals Inc (EGRX) as of September 6, 2022, with a value of $94,016.
Latest Holdings of Richard A. Edlin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EGRX | Eagle Pharmaceuticals Inc | 2022-09-06 | 22,600 | 4.16 | 94,016 |
Holding Weightings of Richard A. Edlin
Richard A. Edlin Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard A. Edlin has made a total of 1 transactions in Eagle Pharmaceuticals Inc (EGRX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Eagle Pharmaceuticals Inc is the sale of 6,800 shares on September 6, 2022, which brought Richard A. Edlin around $210,732.
Insider Trading History of Richard A. Edlin
- 1
Richard A. Edlin Trading Performance
GuruFocus tracks the stock performance after each of Richard A. Edlin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard A. Edlin is 1.15%. GuruFocus also compares Richard A. Edlin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard A. Edlin within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard A. Edlin's insider trading performs compared to the benchmark.
Performance of Richard A. Edlin
Average Return
-33.52%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.01 | 1.15 | -28.06 | -33.52 | -23.28 | -22.81 |
| Relative Return to S&P 500(%) | 11 | -2.51 | -34.61 | -46.09 | -32.49 | -22.19 |
Richard A. Edlin Ownership Network
Ownership Network List of Richard A. Edlin
Ownership Network Relation of Richard A. Edlin
Richard A. Edlin Owned Company Details
What does Eagle Pharmaceuticals Inc do?
Who are the key executives at Eagle Pharmaceuticals Inc?
Richard A. Edlin is the director of Eagle Pharmaceuticals Inc. Other key executives at Eagle Pharmaceuticals Inc include director & President and CEO Scott Tarriff , EVP & Chief Commercial Officer Michael Shawn Moran , and Chief Medical Officer Judith Ng-cashin .
Eagle Pharmaceuticals Inc (EGRX) Insider Trades Summary
Over the past 18 months, Richard A. Edlin made no insider transaction in Eagle Pharmaceuticals Inc (EGRX). Other recent insider transactions involving Eagle Pharmaceuticals Inc (EGRX) include a net sale of 101,864 shares made by Scott Tarriff ,
In summary, during the past 3 months, insiders sold 0 shares of Eagle Pharmaceuticals Inc (EGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 101,864 shares of Eagle Pharmaceuticals Inc (EGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 101,864 shares.
Eagle Pharmaceuticals Inc (EGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eagle Pharmaceuticals Inc Insider Transactions
Richard A. Edlin Mailing Address
Above is the net worth, insider trading, and ownership report for Richard A. Edlin. You might contact Richard A. Edlin via mailing address: C/o Eagle Pharmaceuticals, Inc., 50 Tice Boulevard, Suite 315, Woodcliff Lake Nj 07677.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
